Terumo inks regenerative collab deal with Cognate BioServices September 30, 2016 By Fink Densford Terumo Corp. (TYO:4543) and Cognate BioServices said today they inked a collaborative cellular and immunotherapy products development deal. Get the rest of the story at our sister site, Medical Design & Outsourcing